It's not unusual for the Target company to make concessions to sell assets or parts of its business as part of their closing conditions with the acquiring company in a reverse triangular merger. In our case we have no idea what those conditions really are with the entity that ends up acquiring Amedica, however I found some interesting corrolations with the Bayer-Monsanto merger.
News 
Market Data 
Discover 
